MAPK8 and triple-A syndrome: One line of evidence suggests that JNK activation promotes ECM degradation during AAA pathogenesis by increasing MMP production, specifically MMP9 from THP-1 monocyte–macrophages and Mmp2 from rodent VSMCs [78].